The Portfolio · BriefLatest →
M&A

SAGILITY · SAGILITY LIMITED · BSE · Filed 13 Jun · 1 min read

Sagility to Acquire U.S. Healthcare Analytics Firm CareSeed for up to $30 Million

Sagility's step-down subsidiary Sagility LLC has signed a definitive agreement to acquire 100% of Kansas City-based CareSeed LLC, a NCQA-certified HEDIS reporting platform.

What was filed

Sagility Limited told the exchanges that its board, meeting on June 11, 2026, approved an acquisition by Sagility LLC, a step-down subsidiary. On the same day, Sagility LLC signed a definitive agreement to acquire CareSeed LLC, a U.S. healthcare analytics and technology company. The filing states the deal will be settled in cash, gives an indicative completion period of June 11, 2026, and notes no governmental or regulatory approvals are required. The company confirmed the transaction does not fall within related party transactions.

What CareSeed brings

Per the filing, CareSeed is a healthcare analytics platform offering quality measurement (HEDIS) reporting and risk adjustment solutions to U.S. health plans. It operates an NCQA-certified cloud-based platform covering HEDIS reporting, medical record review and quality analytics. Incorporated in 2012 and headquartered in Kansas City, the company says CareSeed has a presence among 30 mid-sized U.S. health plans. Sagility frames the deal as strengthening its healthcare analytics capabilities and expanding into quality measurement, risk adjustment, STAR performance management and care gap closure services within the payer ecosystem.

How the price is structured

The aggregate consideration is split between a fixed upfront component paid at closing, subject to customary closing adjustments, and a contingent portion tied to the achievement of revenue growth synergies. CareSeed's disclosed turnover has risen steadily over the three calendar years reported in the filing. The specific figures appear in the key-facts panel below.

CareSeed turnover (CY
approximately USD 3.6 → approximately USD 4.0 → approximately USD 5.1 mnFY23 → FY24 → FY25+42%
Aggregate purchase consideration
up to US$ 30 million
Upfront payment at closing
US$ 17.5 million
Contingent consideration
up to US$ 12.5 million
Shareholding acquired
100%

‡ Computed by us from the filing’s own figures — not a company-stated number.

For a Sagility holder, the filing adds an all-cash acquisition of up to US$ 30 million, with a portion contingent on revenue synergies, that expands the company's U.S. payer-focused analytics offering. The relevant figures, including CareSeed's modest disclosed turnover, are set out in the filing for those tracking how the deal sizes against Sagility's existing business.